Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past hour
Any time
Past 24 hours
Past 7 days
Past 30 days
Most recent
Best match
Business Wire
14m
Gilead and Merck Announce Phase 2 Data Showing a Treatment Switch to an Investigational Oral Once-Weekly Combination Regimen of Islatravir and Lenacapav…
Gilead Sciences, Inc. (Nasdaq: GILD) and Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Reaches tentative union deal
Philip Zimbardo dies at 91
Netanyahu's home targeted
OK classroom Bible suit
Frozen waffles recalled
PG&E shuts off power
Three Americans detained
2024 induction ceremony
Fire prompts evacuations
NC breaks turnout record
Emergency abortion ruling
Calif. oil refinery closure
Judge unseals new evidence
Antitrust ruling delayed
G7 ministers back Ukraine
Republicans appeal ruling
Nationwide blackout in Cuba
US deficit reaches $1.8T
NK sending troops to RU?
At decade-high level
$4M LAPD fentanyl seizure
La Nina could arrive soon
Probes near miss in Austin
Challenges military listing
Bladder cancer drug pulled
School shooting report
To furlough 700 workers
Opioid suits settlement deal
Related topics
Trodelvy
United States
NASDAQ
Eli Lilly and Company
HIV
Feedback